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Cognitive dysfunctionThe P50 is anearly componentof auditory evokedpotentials and ameasure of sensory gatingdeﬁcits. This evoked
potential component is thought to be an important endophenotype candidate for schizophrenia. Recent research
suggests that instead of the P50 ratio, S1 and S2 amplitudes should be evaluated for sensory gating. However, no
studies have focused on the relationship between cognitive dysfunction and P50 sensory gating deﬁcits using
S1 and S2 amplitudes. The purpose of the present studywas to investigate the association between the P50 ratio
(S2/S1), S1 and S2 amplitudes, and neuropsychological cognitive domains using stepwise multiple linear
regression analyses. Results demonstrated a signiﬁcant relationship between executive functioning and the P50
ratio and between sustained attention and S2 amplitude, respectively. Ourﬁndings suggest that the P50 ratio and
S2 amplitude reﬂect distinct neurophysiological substrates associated with different cognitive functions.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Perceptual and cognitive deﬁcits are apparent in schizophrenia.
Neuropsychological tests, neuroimaging, and event-related brain
potentials (ERPs) are popularly used to assess for these deﬁcits. The
P50 is an early component of auditory evoked potentials. The P50
response amplitude of the second (S2) or test stimulus [to that of the
ﬁrst (S1) or conditioned stimulus] demonstrates sensory gating.
Deﬁcits in sensory gating are an important endophenotype candidate
for schizophrenia (Braff and Light, 2005; Turetsky et al., 2007).
Although several previous studies have investigated associations
between the P50 ratio and clinical symptoms, researchers have not
conﬁrmed a cross-sectional or longitudinal relationship between P50
sensory gating and speciﬁc clinical symptoms (Potter et al., 2006).
Several studies have investigated the relationship between P50
sensory gating and cognitive dysfunction. Erwin et al. (1998) divided
patients into high- and low-P50 abnormality groups and compared
neuropsychological performance of these two groups. The high-P50
abnormality group showed greater deﬁcits in attention proﬁle scores
compared to performance on other neuropsychologicalmeasures. Cullum
et al. (1993) compared patients with schizophrenia and control subjects
with respect to P50 sensory gating and memory and attention and found
P50 abnormalities aswell as deﬁcits in sustained attention in the patients.
Sanchez-Morla et al. (2013) evaluated P50 sensory gating between
160 patients with schizophrenia and 64 normal controls. The authors+81 11 706 5081.
maki@gmail.com
c. This is an open access article unddid not observe a signiﬁcant association between the P50 ratio and the
neuropsychological tests they employed. Using magnetoencephalog-
raphy (MEG), Thoma et al. (2003) showed that compared to control
subjects, patients with schizophrenia have sensory gating abnormal-
ities reﬂected by the M50 (which corresponds to the P50 component)
and signiﬁcant correlations between the M50 and sustained attention
and working memory. Although these small-sample studies indicate
that P50 (orM50) sensory gatingmight be associated speciﬁcally with
attention and memory, among the various cognitive domains
impaired in schizophrenia, a large-sample study by Sanchez-Morla
et al. (2013) observed no association between the P50 ratio and
cognitive functioning. Therefore, no clear association between P50
sensory gating and cognitive dysfunction has been established.
Recent research has proposed that rather than the P50 ratio, S1
and S2 amplitudes should be evaluated in terms of sensory gating.
Indeed, a meta-analysis assessing the P50 ratio (S2/S1) and S1 and S2
amplitudes in schizophrenia revealed that overall effect sizes for the
P50 ratio, S1 amplitude, and S2 amplitude were 0.93 (large), 0.19
(small), and 0.65 (medium to large), respectively (Chang et al., 2011).
Since the S2 amplitude effect is medium to large, some authors argue
in favor of increasing the importance of this amplitude with regard to
schizophrenia. For example, Shan et al. (2010) assessed P50 sensory
gating among 81 patients with schizophrenia and 47 normal controls,
reporting that S2 amplitudes were larger among the patients
compared to normal controls. Conversely, Jansen et al. (2010)
measured P50 sensory gating among 25 patients with schizophrenia
and 25 normal controls and demonstrated a signiﬁcant S1 amplitude
reduction among the patients. These ﬁndings suggest that S1 and S2
amplitudes are sensitive to sensory gating and suitable for quantita-
tive analysis. However, the three aforementioned ERP studies, whicher the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Neurophysiological and neurocognitive measures in patients with schizophrenia.
Mean (SD)
Neurophysiological measures
S1 amplitude 1.22 (0.57)
S2 amplitude 0.83 (0.61)
P50 ratio 0.78 (0.62)
Neurocognitive measures
WCST CA 4.3 (1.6)
WCST PEM 3.1 (5.1)
WCST PEN 5.1 (5.7)
CPT errors 3.8 (5.2)
CPT reaction time 416.6 (76.0)
WFT sums 28.6 (10.1)
Stroop errors 0.8 (1.2)
Stroop RT differences 8.3 (4.6)
TMT-A 92.6 (29.3)
TMT-B 113.2 (43.3)
TMT RT differences 20.6 (35.5)
AVLT immediate 5.2 (1.2)
AVLT delay 6.3 (2.1)
For abbreviation of neuropsychological tests see Section 2.
Table 2





P50 ratio S2 amplitude
R R2 SE P R R2 SE P
WCST PEN 0.434 0.188 60.397 0.013 – – – –
CPT reaction time – – – – 0.456 0.208 0.464 0.009
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functioning, only assessed the P50 ratio.
The purpose of the present study was to investigate the association
between the P50 ratio (S2/S1), S1 and S2 amplitudes, and neuropsy-
chological cognitive domains using stepwise multiple linear regression
analyses. While, P50 sensory gating is less affected by ﬁrst- and
second-generation antipsychotic drugs (Adler et al., 2004; Su et al.,
2012), clozapine and high-dose quetiapine tend to improve abnormal
P50 sensory gating among patients with schizophrenia (Adler et al.,
2004;Oranjeet al., 2013). Thus, thepresent study recruitedpatientswith
schizophrenia whowere administered second-generation antipsychotic
drugs, with the exception of clozapine and high-dose quetiapine.
2. Methods
2.1. Participants
Forty-one (16 females, 25 males) schizophrenic patients who met
DSM-IV criteria were assessed with electrophysiological measurements
and neuropsychological tests. Patients' mean age was 29.3 years (SD =
7.8 years). The mean duration of illness was 5.4 years (SD = 5.9).
Patients were taking the following second-generation antipsychotic
drugs at the time of testing: aripiprazole (n = 5, mean CPZ equivalent
dose ± SD, 345.0 ± 257.6 mg/day), blonanserin (n = 1, CPZ equiva-
lent dose, 300.0 mg/day), olanzapine (n = 7, mean CPZ equivalent
dose ± SD, 685.7 ± 323.7 mg/day), perospirone (n = 8, mean CPZ
equivalent dose ± SD, 301.4 ± 243.0 mg/day), quetiapine (n = 12,
mean CPZ equivalent dose ± SD, 556.2 ± 438.5 mg/day), or
risperidone (n = 13, mean CPZ equivalent dose ± SD,
407.7 ± 262.9 mg/day). Some patients were taking anticholinergic
agent, Biperiden (n = 10, mean dose ± SD, 3.2 ± 1.7 mg/day), anti-
depressants (n = 9, mean imipramine equivalent dose ± SD,
113.9 ± 75.1 mg/day). Thirty-four patients were taking anxiolytics
(mean diazepam equivalent dose ± SD, 30.9 ± 37.0 mg/day). Clinical
symptomswere assessedwith the Positive andNegative SyndromeScale
(Kay et al., 1987). The mean values for positive, negative, and general
psychopathology scale scorewere20.4 (SD = 7.1), 20.6 (SD = 7.7), and
42.1 (SD = 24.6), respectively. The local ethics committee from
Hokkaido University approved this study. After a complete study
explanation, subjects provided written informed consent.
2.2. EEG recording and analysis
Electroencephalogram (EEG: bandpass 0.16–30 Hz, digitized at
500 Hz) recording was obtained from Fz, Cz, and Pz electrodes
according to the international 10/20 system. Ag/AgCl electrodes
were used, and impedance was kept below 10 kΩ. All electrodes
were referenced to the earlobes. Electro-oculogram (EOG) recording
was gathered from electrodes lateral to and below the left eye. The
paired-click paradigm was performed to elicit the P50 component. A
pure tone (1500 Hz, 6-ms duration, 80 dB SPL) was used as the click
sound and presented during a 500-ms interval through a loudspeaker.
The interval between paired stimuli was 8 seconds. The signals were
digitized for an epoch of 400 ms starting 200 ms prior to the
presentation of each auditory stimulus. Individual trials were rejected
when EEG voltage was greater than ±35 μV, indicative of excessive
muscle activity, eyemovements, or other artifacts.We deﬁned the P50
component as the most positive peak between 30 and 70 ms
post-stimulus onset. We measured the peak-to-peak P50 amplitude
from a preceding negative trough to the positive peak. This was done
because the baseline prior to the second stimulus onset often
ﬂuctuated based on the ERP from the ﬁrst stimulus; the base-
line-to-peak P50 amplitude was not appropriate for assessment. The
P50 ratio was calculated as the test stimulus response dived by theconditioning stimulus response.Wepresented the paired stimulus 300
times, which provided 40 minutes of EEG measurement. In consider-
ation of participant load and ear comfort that could inﬂuence EEG
measurement, we instructed participants to watch a silent ﬁlm and
presented auditory stimuli from a loudspeaker as mentioned above.
2.3. Neuropsychological assessment
A battery of neuropsychological tests was administered to all
patients. The neuropsychological tests used, and related cognitive
domain, were as follows: Wisconsin Card Sorting Test (WCST),
executive function; Word Fluency Test (WFT), verbal ﬂuency;
Continuous Performance Test (CPT), sustained attention and motor
speed; Trail Making Test (TMT), visual-motor processing and motor
speed; Auditory Verbal Learning Test (AVLT), verbal learning and
immediate and recent memory; and Stroop Test, selective attention.
For the WCST, a computerized Japanese Keio University version was
used. We assessed category of achievement (CA) and two types of
perseverative errors (Nelson and Milner perseverative errors). The
CPT was a computerized A-X CPT test administered for approximately
8 minutes. Several characters were presented on the center of a
monitor, and subjects were instructed to respondwith an “X” after “A”
was presented, as soon as possible. The target stimulus was presented
70 times. Each stimulus was presented for 100 ms, and the
inter-stimulus interval varied from 1500 to 2000 ms. We assessed
both the number of errors and reaction time (RT). The TMT was
administered based on a standard procedure, which consists of the
TMT-A and TMT-B (Shum et al., 1990). We measured the amount of
time required to complete the TMT-A and TMT-B, respectively, and
assessed the time to completion between the two (TMT-B minus
TMT-A). The WFT was administered from a Japanese version that
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from each of three Japanese, cursive syllables (“si,” “i,” and “re”) for
1 minute. We counted the total number of produced words across the
three conditions. The Stroop test used was a Japanese version
consisting of two ﬁgures on A4 sized paper. The former had 24 circles
painted with red, blue, yellow, and green ink. The patients were
instructed to read aloud the color name (congruent condition). The
latter condition consisted of 24 Chinese characters indicating one of
the above four colors, but each character was painted in a different
color from its meaning. Patients had to read the color name rather
than the characters (incongruent condition). We counted the number
of errors in the incongruent condition and assessed RT differences
between the two conditions (incongruent minus congruent). The
AVLT was developed using a normed procedure to measure both
immediate memory and recent memory. We orally presented 10,
commonly used Japanese words 5 times. The patients, during each
trial, were instructed to recall as many of the words as possible.
Patients completed the 4th recall session after 30 minutes and then
were asked to recall the full list for the 5th recall session. We counted
the number of recalled words across the 5 sessions. We regarded the
1st recall session as “immediate memory” and the 5th recall as
“recent memory.”
2.4. Statistical analysis
In order to assess relationships between cognitive domains and
P50 sensory gating, several stepwise regressions were performed on
the neuropsychological tests, P50 ratio, and S1 and S2 amplitudes.
Independent variables were the P50 ratio and S1 and S2 amplitudes,
and the predicted variables were as follows: WCST CA (category of
achievement); WCST PEM (Milner perseverative errors); WCST PEN
(Nelson perseverative errors); CPT errors, CPT RT, and WFT sums;
Stroop errors; Stroop RT differences; TMT-A, TMT-B, and TMT RT
differences; AVLT immediate; AVLT delay.
3. Results
Table 1 shows neurophysiological measures (S1 and S2 amplitude,
P50 ratio) and neurocognitivemeasures. A stepwisemultiple regression
analysis using the P50 ratio as the dependent variable demonstrated
that more Nelson perseverative errors during the WCST (WCST PEN)
were associatedwith an increased P50 ratio (p b .05). A second analysis
using S1 amplitude as the dependent variable did not ﬁnd any
signiﬁcant relationships. However, an analysis using S2 amplitude as
thedependent variable revealed that longerRTsduring theCPT (CPTRT)
were associated with an increase in S2 amplitude (p b .001).
Generally, the P50 ratio and S2 amplitude appear to be higher
among schizophrenic patients as compared to normal, control
subjects. Our ﬁndings suggest that an increased P50 ratio or S2
amplitude is associated with cognitive deﬁcits. Table 2 shows results
from our stepwise multiple regression models.
4. Discussion
The purpose of the present study was to investigate associations
between P50 sensory gating (P50 ratio, S1 and S2 amplitudes) and
neuropsychological functioning. The P50 ratio and S1 and S2
amplitudes were used as dependent variables for a series of multiple
regression analyses. We observed associations between executive
functioning (WCST PEN) and the P50 ratio and between sustained
attention (CPT RT) and S2 amplitude, respectively.
Interestingly, it appears the P50 ratio and S2 amplitude might
reﬂect different cognitive domains. These results are somewhat
different from those previously reported. For instance, previousstudies have typically just focused on the P50 ratio. Two studies
demonstrated an association between attention and the P50 ratio
(Cullum et al., 1993; Erwin et al., 1998), while one large-scale study
revealed no signiﬁcant association between the P50 ratio and
neuropsychological functioning (Sanchez-Morla et al., 2013). The
two studies observing associations between the P50 ratio and
attention did not measure executive functioning per se, but
Sanchez-Morla and Santos utilized Wisconsin Card Sorting Test
performance, one of the tests used in the present study. Our results
regarding the association between the P50 ratio and executive
functioning was different from these previous studies in two ways.
Firstly, we did not ﬁnd any signiﬁcant relationships between the P50
ratio and any attention domain. Cullum et al. (1993) did not use the
CPT or any other measure assessing RT. Erwin et al. (1998) did use the
CPT, which was a bit different from that used in our study, but did not
calculate RT. Thus, neither study measured RT during sustained
attention; thus, differences in attentional measures among studies
might contribute to the observed inconsistencies. Secondly, a
signiﬁcant association between Nelson perseverative errors during
the WCST was observed in our study. Sanchez-Morla et al. (2013)
converted raw scores to a T-score distribution in terms of the number
and type of perseverativeWCST errors. The present study utilized raw
Nelson and Milner perseverative error scores. However, we assumed
these differences likely would not be critical to the inconsistencies
between studies; nevertheless, further study is needed to better
determine the disparate ﬁndings observed.
Another intriguing observation was that CPT RT predicted
increases in S2 amplitude. Although some previous studies demon-
strated that S2 amplitude itself was higher among schizophrenia
patients compared to normal controls (Shan et al., 2010, 2013), no
studies had previously investigated relationships between cognitive
performances and S2 amplitude. It is not surprising that neurophys-
iological processing related to the S2 response would differ from the
P50 ratio. Thus, the P50 response relating to S2 might be suppressed by
an auditory sensory representation of S1. Therefore, encoding processes
(e.g., sensory registration) could be substantially reduced. These
S2-speciﬁc neural processes provided contributions through activation
of GABAergic interneurons via cholinergic inputs in the hippocampus
(Vlcek et al., 2014). The S2 response is sensitive to evaluative processes,
especially when encoding information is related to preceding informa-
tion. From here, we can argue that the S2 response shares common
processes with RT performance during the CPT.
5. Conclusions
Based on the present ﬁndings, it appears that the P50 ratio and S2
amplitude reﬂect distinct neurophysiological substrates, revealing
differential associations with higher cognitive functions. Although the
P50 ratio is one of the more important endophenotype candidates for
schizophrenia (Braff and Light, 2005; Turetsky et al., 2007), the present
study suggests that focusing on multidirectional measures of P50
abnormality (i.e., S1 and S2 amplitudes) is important to further explore
cognitive aspects related to sensory gatingdysfunction in schizophrenia.
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